These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8159305)

  • 1. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
    Böhler J; Schollmeyer P; Dressel B; Dobos G; Hörl WH
    J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate.
    Haag-Weber M; Mai B; Deppisch R; Göhl H; Hörl WH
    Clin Nephrol; 1994 Apr; 41(4):245-51. PubMed ID: 8026120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood flow dependent granulocyte activation in membranes with and without complement activation.
    Böhler J; Donauer J; Schollmeyer P; Hörl WH
    Adv Exp Med Biol; 1991; 297():215-24. PubMed ID: 1767753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
    Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
    Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and neutrophil aggregation changes during haemodialysis.
    Kubatiev A; Rudko I; Ermolenko V
    Int J Clin Pharmacol Res; 1993; 13(6):293-9. PubMed ID: 8088929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.
    Hörl WH; Feinstein EI; Wanner C; Frischmuth N; Gösele A; Massry SG
    Am J Nephrol; 1990; 10(1):53-7. PubMed ID: 2343881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockers.
    Haag-Weber M; Schollmeyer P; Hörl WH
    Eur J Clin Invest; 1988 Aug; 18(4):380-5. PubMed ID: 3139423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the dialysate fluid source of complement activating factors?
    Minetti L; Broggi ML; Civati G; Guastoni C; Teatini U
    Trans Am Soc Artif Intern Organs; 1985; 31():673-7. PubMed ID: 3879782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of dialysis membranes: a comparative study.
    Martin-Malo A; Castillo D; Castro M; Pérez R; Rios A; Jaraba M; Aljama P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():55-8. PubMed ID: 1866069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of myeloperoxidase and elastase are differentially regulated by hemodialysis membranes and anticoagulants.
    Ono K; Ueki K; Inose K; Tsuchida A; Yano S; Nojima Y
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):341-9. PubMed ID: 11958287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction between blood and dialysis membrane].
    Szepietowski T; Orłowski A
    Polim Med; 1991; 21(3-4):3-13. PubMed ID: 1822594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study.
    Danielson BG; Hällgren R; Venge P
    Blood Purif; 1986; 4(1-3):147-50. PubMed ID: 3524607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protein adsorption on haemodialysis-induced complement activation and neutrophil defects.
    Neveceral P; Markert M; Wauters JP
    Nephrol Dial Transplant; 1995; 10(3):372-6. PubMed ID: 7792033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
    Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.